Group 1 - The core viewpoint of the news highlights the positive market response and policy support for the innovative drug sector, particularly through the recent ETF performance and government procurement policies [1][2]. - The innovative drug ETF (560900) experienced a significant increase in trading volume and net inflow of funds, reaching a new high in both scale and shares [1]. - The National Medical Insurance Administration has initiated the 11th batch of centralized drug procurement, establishing clear guidelines that protect innovative drugs, thereby boosting confidence in R&D and commercialization for innovative drug companies [2]. Group 2 - The new procurement policy is expected to enhance the commercialization path for innovative drugs, facilitating market penetration and sales growth [2]. - The innovative drug ETF closely tracks the CSI Innovative Drug Industry Index, which includes a maximum of 50 representative listed companies involved in innovative drug R&D [2]. - Morgan Asset Management is integrating its global technology investment products to help investors capitalize on opportunities in quality tech companies amid the rise of AI-driven technological advancements [2].

- The report does not contain any quantitative models or factors for analysis[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][30][31][32][33][34][35][36][37][38][39][40][41]

一、ETF行业快讯 1.三大指数集体上涨，多只建材板块ETF大涨 今日，三大指数集体上涨，上证综指上涨0.72%，深证成指上涨0.86%，创业板指上涨0.87%。多只建材 板块ETF大涨，其中，建材ETF（516750.SH）上涨10.05%，建材ETF（159745.SZ）上涨9.97%，建材 ETF易方达（159787.SZ）上涨9.94%。医药生物板块多只ETF下跌，创新药企ETF（560900.SH）下跌 1.46%，药ETF（562050.SH）下跌1.32%，创新药ETF国泰（517110.SH）下跌1.08%。 兴业证券表示，建材板块2024年现金分红比例为61.39%，股息率为2.29%（采用2025年7月18日股价计 算）。从基本面的角度来看，2024年城中村改造、保障房建设等有望托底地产需求，建材细分领域龙头 将继续演绎市占率提升，经营业绩有望稳健增长，因此我们建议关注业绩稳健、低估值、高股息的消费 建材龙头。 2.中央汇金二季度加仓多只宽基ETF 据智通财经，7月21日，根据最新披露的基金二季报，中央汇金投资有限责任公司（以下简称 "中央汇 金"）在4月至6月期间密集加仓沪深300、上证 ...

Group 1 - The ETF market showed mixed performance at midday, with the construction material ETFs leading the gains [1] - E Fund Construction Material ETF (159787) rose by 8.23%, while other construction material ETFs also saw significant increases of 7.88% and 7.60% [1] - The S&P Biotechnology ETF (159502) was the biggest loser, declining by 1.91%, followed by the Huabao AI ETF (159363) down 1.51% and the Innovative Drug ETF (560900) down 1.46% [1]